AIRLINK 66.80 Increased By ▲ 2.21 (3.42%)
BOP 5.67 Increased By ▲ 0.07 (1.25%)
CNERGY 4.63 Decreased By ▼ -0.09 (-1.91%)
DFML 22.32 Increased By ▲ 1.56 (7.51%)
DGKC 69.76 Decreased By ▼ -1.64 (-2.3%)
FCCL 19.62 Decreased By ▼ -0.33 (-1.65%)
FFBL 30.20 Decreased By ▼ -0.25 (-0.82%)
FFL 9.90 Decreased By ▼ -0.15 (-1.49%)
GGL 10.05 No Change ▼ 0.00 (0%)
HBL 115.70 Increased By ▲ 4.70 (4.23%)
HUBC 130.51 Decreased By ▼ -0.33 (-0.25%)
HUMNL 6.74 Decreased By ▼ -0.11 (-1.61%)
KEL 4.35 Decreased By ▼ -0.04 (-0.91%)
KOSM 4.80 Increased By ▲ 0.46 (10.6%)
MLCF 37.19 Decreased By ▼ -0.56 (-1.48%)
OGDC 133.55 Decreased By ▼ -0.30 (-0.22%)
PAEL 22.60 Increased By ▲ 0.03 (0.13%)
PIAA 26.70 Decreased By ▼ -0.85 (-3.09%)
PIBTL 6.25 Decreased By ▼ -0.06 (-0.95%)
PPL 113.95 Decreased By ▼ -1.00 (-0.87%)
PRL 27.15 Decreased By ▼ -0.07 (-0.26%)
PTC 16.13 Decreased By ▼ -0.37 (-2.24%)
SEARL 59.70 Decreased By ▼ -1.00 (-1.65%)
SNGP 66.50 Increased By ▲ 1.35 (2.07%)
SSGC 11.21 Decreased By ▼ -0.14 (-1.23%)
TELE 8.94 Decreased By ▼ -0.03 (-0.33%)
TPLP 11.34 Increased By ▲ 0.09 (0.8%)
TRG 69.36 Increased By ▲ 0.31 (0.45%)
UNITY 23.45 Increased By ▲ 0.01 (0.04%)
WTL 1.36 Decreased By ▼ -0.03 (-2.16%)
BR100 7,312 Decreased By -12.8 (-0.17%)
BR30 24,106 Increased By 48.2 (0.2%)
KSE100 70,484 Decreased By -60.9 (-0.09%)
KSE30 23,203 Increased By 11.5 (0.05%)

GlaxoSmithKline

Britain's GSK exits US drugmaker Innoviva in $392mn deal
Business & Finance

Britain's GSK exits US drugmaker Innoviva in $392mn deal

  • The London-listed company said it sold roughly 32 million shares in the Nasdaq-listed Innoviva for $12.25 per share, a marginal discount to the stock's closing price of $12.29 on Wednesday.
  • Shares of GSK were 0.3% lower at 1,361.3 pence by 1427 GMT, while Innoviva gained 5.1% to about $13.
Published 20 May, 2021 09:16pm
Member to Member
Markets

Member to Member

KARACHI: The following transactions member to member subsequently reported on Friday
Published 10 Apr, 2021 04:35am
Member to Member
Markets

Member to Member

KARACHI: The following transactions member to member subsequently reported on Thursday (April 8, 2021)....
Published 09 Apr, 2021 04:51am
GLAXO fares well
BR Research

GLAXO fares well

The pharmaceutical industry has remained largely undeterred by the event of Covid-19, mainly because of nature of ...
Published 15 Mar, 2021 07:40am
GSK narrows focus on elderly in trial to treat pneumonia from COVID-19
Business & Finance

GSK narrows focus on elderly in trial to treat pneumonia from COVID-19

  • A trial started in May last year has shown that the drug known as otilimab helps patients over 70 with severe COVID-19 get off mechanical ventilation or high-flow oxygen support faster.
  • The benefit for younger trial participants was not clear enough to merit further investigation, prompting the re-focus on the elderly in a follow-up trial with a targeted 350 participants.
Published 25 Feb, 2021 07:08pm